TrialCancer discovery2020

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.

Seth A Wander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.